Georgia Hemp Farming Act; provide limits on the total concentration of THC and other intoxicating cannabinoids in consumable hemp products
HB265 amends Georgia’s Hemp Farming Act to impose new limits and testing requirements on consumable hemp products. The bill defines and regulates a broad category of “THC and other intoxicating cannabinoids,” including delta-8, delta-9, delta-10, THCA, THC-O, THCP, THCV, HHC, and related compounds, and bars sale or distribution of consumable hemp products whose total concentration of these substances exceeds 0.3 percent on a dry-weight basis where applicable. It also revises definitions throughout the hemp code to distinguish hemp, hemp products, industrial hemp products, processors, manufacturers, retailers, and laboratories.
The bill requires a current full-panel certificate of analysis from an unaffiliated accredited laboratory for consumable hemp products, with testing for specified cannabinoids and contaminants, and requires products to bear a department-approved THC warning sticker and a label or QR code linking to the analysis. The Department of Agriculture is authorized to conduct random inspections and testing of retail products, and products that fail labeling, potency, contaminant, or composition requirements must be disposed of under department rules. Violations of the core consumable-hemp provisions are made misdemeanors.
HB265 also places specific packaging and product-form restrictions on consumable hemp items. It prohibits consumable hemp products from being sold as part of a food product or as part of alcoholic drinks or beverages, while allowing hemp in gummies or consumable base oils if they are not components of food products. For gummies, the bill sets a maximum of 5 milligrams of THC and other intoxicating cannabinoids per serving and 150 milligrams per container when multiple servings are sold.
The overall sentiment reflected by the bill text is regulatory and precautionary rather than permissive, focusing on consumer safety, product transparency, and tighter control of intoxicating hemp-derived products. No committee transcripts or recorded votes were provided, so there is no documented debate or formal vote history to indicate broader legislative support or opposition. Based on the bill’s structure, likely points of contention would include the scope of the cannabinoid ban/limit, the practical burden of testing and labeling requirements on hemp businesses, and the restriction on gummies and food/beverage products.
HB265 would substantially revise Georgia’s hemp law by tightening the legal treatment of consumable hemp products, expanding statutory definitions to cover a wide range of intoxicating cannabinoids, and creating enforceable product standards for potency, testing, labeling, and contamination. It would affect hemp processors, manufacturers, retailers, laboratories, and the Department of Agriculture, while also creating misdemeanor liability for certain violations and requiring disposal of noncompliant products.
The bill’s tone is strongly regulatory and consumer-protective, aiming to curb intoxicating hemp products and improve product safety and transparency. Because no committee discussion or vote record was provided, there is no direct evidence of support or opposition from legislators, industry stakeholders, or the public in the available materials.
The main likely points of contention are the breadth of the definition of “THC and other intoxicating cannabinoids,” the 0.3 percent total concentration cap, the mandatory full-panel testing and labeling requirements, and the strict gummy dosage limits. Hemp businesses and retailers may view these provisions as burdensome or restrictive, while supporters would likely argue they are necessary to protect consumers, especially minors, from mislabeled or overly potent products.